Autocrine Bradykinin Release Promotes Ischemic Preconditioning-Induced Cytoprotection in Bovine Aortic Endothelial Cells
Open Access
- 22 April 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (8), 2965
- https://doi.org/10.3390/ijms21082965
Abstract
The aims of this study were to assess whether ischemic preconditioning (PC) induces bradykinin (Bk) synthesis in bovine aortic endothelial cells (bAECs) and, if so, to explore the molecular mechanisms by which this peptide provides cytoprotection against hypoxia. PC was induced by exposing bAECs to three cycles of 15 min of hypoxia followed by 15 min of reoxygenation. Bk synthesis peaked in correspondence to the early and late phases of PC (10−12 M and 10−11 M, respectively) and was abolished by a selective tissue kallikrein inhibitor, aprotinin. Stimulation with exogenous Bk at concentrations of 10−12 M and 10−11 M reduced the cell death induced by 12 h of hypoxia by 50%. Pretreatment with HOE−140, a Bk receptor 2 (BKR2) inhibitor, in bAECs exposed to 12 h of hypoxia, abrogated the cytoprotective effect of early and late PC, whereas des-Arg-HOE-140, a Bk receptor 1 (BKR1) inhibitor, affected only the late PC. In addition, we found that PC evoked endocytosis and the recycling of BKR2 during both the early and late phases, and that inhibition of these pathways affected PC-mediated cytoprotection. Finally, we evaluated the activation of PKA and Akt in the presence or absence of BKR2 inhibitor. HOE-140 abrogated PKA and Akt activation during both early and late PC. Consistently, BKR2 inhibition abolished cross-talk between PKA and Akt in PC. In bAECs, Bk-synthesis evoked by PC mediates the protection against both apoptotic and necrotic hypoxia-induced cell death in an autocrine manner, by both BKR2- and BKR1-dependent mechanisms.This publication has 52 references indexed in Scilit:
- Cross-Talk Between PKA and Akt Protects Endothelial Cells From Apoptosis in the Late Ischemic PreconditioningArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Bradykinin Protects Against Oxidative Stress–Induced Endothelial Cell SenescenceHypertension, 2009
- Angiotensin-Converting Enzyme Inhibition After Experimental Myocardial InfarctHypertension, 2008
- Role of tissue kallikrein in the cardioprotective effects of ischemic and pharmacological preconditioning in myocardial ischemiaThe FASEB Journal, 2005
- In Vivo and in Vitro Phosphorylation of Two Isoforms of Yeast Pyruvate Kinase by Protein Kinase AOnline Journal of Public Health Informatics, 2002
- Kinin-Degrading Pathways in the Human HeartTrends in Cardiovascular Medicine, 2000
- Role of Kinins in the Cardioprotective Effect of PreconditioningHypertension, 1997
- Ligand-induced Phosphorylation/Dephosphorylation of the Endogenous Bradykinin B2 Receptor from Human FibroblastsJournal of Biological Chemistry, 1996
- Paracrine modulation of heart cell function by endothelial cellsCardiovascular Research, 1996
- Tissue Kallikrein Activity and Kinin Release in Human Endothelial Cellscclm, 1994